MYC and small cell lung carcinoma: Importantly, fimepinostat was the most effective drug against all mouse derived cell lines irrespective of their platinum resistance or MYC expression status (Fig. 1B) suggesting that fimepinostat may be broadly effective in the treatment of SCLC.